As molecule complexity rises, advanced cell line development platforms are giving biopharma companies new tools to overcome ...
License agreement provides Rentschler Biopharma full access to ATUM's Leap-In Transposase cell line development (CLD) tools Technology will be integrated into Rentschler Biopharma's in-house process ...
A biotech company pioneering transposases for cell line engineering claims to have widened the applications of these tools. Oren Beske, PhD, gave a talk at BioProcess International, about how ATUM is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results